Cytogenetics in acute leukemia (Q34304230)

1 August 2017

1 reference

title

Cytogenetics in acute leukemia (English)

1 reference

1 August 2017

1 reference

3

Clara D Bloomfield

1 reference

1 August 2017

1

Krzysztof Mrózek

1 reference

1 August 2017

2

Nyla A Heerema

1 reference

1 August 2017

1 June 2004

1 reference

1 August 2017

1 reference

1 August 2017

18

1 reference

1 August 2017

115-136

1 reference

1 August 2017

2

1 reference

Transcription factor fusions in acute leukemia: variations on a theme.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The clinical significance of karyotype in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical importance of cytogenetics in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prognostic factors in infants with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21).

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The prognostic significance of trisomy 8 in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Typical CBFbeta/MYH11 fusion due to insertion of the 3'-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

EVI1 expression in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The importance of cytogenetic studies in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetic aberrations in adult acute lymphocytic leukemia: optimal technique may influence the results.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B-lineage acute lymphoblastic leukaemia in first or second remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Expression of TEL-AML1 Fusion Transcripts and Response to Induction Therapy in Standard Risk Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

del(5q) in acute lymphoblastic leukemia with biphenotypic and early progenitor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Translocation t(5;14)(q35;q32) in three cases of childhood T cell acute lymphoblastic leukemia: a new recurring and cryptic abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetic study of 130 childhood acute nonlymphocytic leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Cytogenetics of childhood acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900040-7

7 January 2021

10.1016/S0268-960X(03)00040-7

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

15010150